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Phosphatidylinositol 4,5-bisphosphate
(PIP2) controls magnesium gatekeeper
TRPM6 activity
Jia Xie1, Baonan Sun1, Jianyang Du1, Wenzhong Yang1, Hsiang-Chin Chen2, Jeffrey D. Overton2,
Loren W. Runnels2 & Lixia Yue1
1From Calhoun Cardiology Center, Department of Cell Biology, University of Connecticut Health Center, Farmington, CT,
2Department of Pharmacology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey, USA.
TRPM6 is crucial for human Mg21 homeostasis as patients carrying TRPM6 mutations develop
hypomagnesemia and secondary hypocalcemia (HSH). However, the activation mechanism of TRPM6 has
remained unknown. Here we demonstrate that phosphatidylinositol-4,5-bisphophate (PIP2) controls
TRPM6 activation and Mg21 influx. Stimulation of PLC-coupled M1-receptors to deplete PIP2 potently
inactivates TRPM6. Translocation of over-expressed 5-phosphatase to cell membrane to specifically
hydrolyze PIP2 also completely inhibits TRPM6. Moreover, depolarization-induced-activation of the
voltage-sensitive-phosphatase (Ci-VSP) simultaneously depletes PIP2 and inhibits TRPM6. PLC-activation
induced PIP2-depletion not only inhibits TRPM6, but also abolishes TRPM6-mediated Mg21 influx.
Furthermore, neutralization of basic residues in the TRP domain leads to nonfunctional or dysfunctional
mutants with reduced activity by PIP2, suggesting that they are likely to participate in interactionswith PIP2.
Our data indicate that PIP2 is required for TRPM6 channel function; hydrolysis of PIP2 by PLC-coupled
hormones/agonists may constitute an important pathway for TRPM6 gating, and perhaps Mg21
homeostasis.
M
agnesium (Mg21) is the most abundant divalent cation in the mammalian cell and is essential for
numerous fundamental cellular processes, including cell cycle, channel regulation, ATPase activity,
metabolic regulation, and various signaling pathways1. Mg21 deficiency has been implicated in many
diseases, ranging from neurological to cardiovascular diseases2, 3. Mg21 homeostasis is therefore tightly controlled
by maintaining the equilibrium between intestinal Mg21 absorption and renal Mg21 excretion/re-absorption.
Several Mg21 transporters and channels have been implicated to be important in Mg21 absorption and/or
reabsorption4–11. Most notable, loss of function of TRPM6 causes familial hypomagnesemia and secondary hypo-
calcemia (HSH)9, 10. TRPM7, the closest homologue of TRPM6, was demonstrated to be essential for cellular Mg21
homeostasis inDT-40 lymphocytes11. However, it’s role inMg21 homeostasis inmice remains disputed12, 13. TRPM6
and TRPM7 are unique bi-functional channel proteins with protein kinase function14–18. TRPM7 is ubiquitously
expressed in various cells and tissues and has well defined functions in embryonic development12, 13, 19, neuronal cell
death20, and a variety of other functions21–24. Different from TRPM7, TRPM6 expression is restrained in the
epithelial cells in intestine and distal convoluted tubule (DCT) of nephron9, 10, consistent with its central role in
controlling Mg21 homeostasis.
Mg21 homeostasis is regulated by a variety of hormonal and pathological conditions1. As a gatekeeper of
humanMg21 homeostasis25, TRPM6 has been demonstrated to be regulated at expression levels2, 26 by hormones
such as estrogen26 and AngII27, metabolic acidosis/alkalosis28, immunosuppressant tacrolimus29, diuretics
Thiazide30, and EGF31. However, the gating mechanism of TRPM6, the key property which controls Mg21 influx,
has remained elusive. Like TRPM7, TRPM6 is inhibited by millimolar concentration of intracellular Mg21
([Mg21]i); therefore, it only constitutively opens to a small degree under physiological [Mg21]i18. Both TRPM6
and TRPM7 are permeable to Ca21 and Mg21 under physiological pH, and conduct monovalent Na1 currents at
acidic extracellular pH32, 33; however, they display significant differences in single channel conductance, phar-
macological profiles32, 33, and kinase activity17. Unlike TRPM7whose channel activity is known to be controlled by
PIP234, how TRPM6 is gated is not clear.
Here, we show that TRPM6 channel activity and TRPM6-mediated Mg21 influx are controlled by PIP2 levels.
Depletion of PIP2 by Gq-linked receptor activation, by depolarization-induced activation of voltage-dependent
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phosphatase (Ci-VSP), and by chemical translocation of 5-phospha-
tase, can all efficiently inactivate TRPM6. Neutralization of the posi-
tively charged residues in the TRP domain leads to dysfunctional or
nonfunctional mutants with reduced single channel activity by PIP2,
suggesting that these positively charged residues are likely to be the
putative PIP2 binding sites. Furthermore, we demonstrate that
the kinase domain of TRPM6 interacts with PLC isoforms, although
the interaction is not necessary for PLC-induced TRPM6 channel
inactivation. These results indicate that PIP2 controls TRPM6 gating,
and perhaps Mg21 homeostasis, under various physiological/patho-
logical conditions.
Results
Phospholipase C stimulation inactivates the TRPM6 channel.
Magnesium homoestasis is tightly controlled by many hormone/
receptor interactions. In order to understand how TRPM6 gating
is regulated, we first determined whether activation of G protein
coupled receptor induced PIP2 hydrolysis has any effect on
TRPM6 activation. TRPM6 was transfected to HEK-293 cells stably
expressing the M1 receptor (HM1). Under whole cell configuration,
TRPM6 current was small right after rupture, and ran up with time
when intracellular free Mg21 concentration was decreased after
pipette solution dialyzed into the cell. Upon TRPM6 current reach-
ing a steady-state, 200 mM carbachol (CCh) was applied to the cell
(Fig. 1A). TRPM6 current was rapidly and almost completely inhi-
bited by CCh application (Fig. 1A–B), suggesting that activation
of the M1 receptor by CCh inactivates TRPM6 channel activity. In
agreement with this notion, CCh failed to inhibit TRPM6 current in
HEK-293 cells transfected with TRPM6 but without over-expression
ofM1 receptor (sFig. 1). Ca21 release induced by CChwas detected in
HM1 cells but not in HEK-293 cells, further suggesting that HEK-
293 cells lack M1 receptor (sFig. 1). In order to determine whether
M1 receptor stimulation induced inactivation of TRPM6 is through
the PLC pathway, we tested the effect of PLC inhibitor U-73122.
However, we found that both the PLC inhibitor U-73122 and its
inactive isoform U-73343 inhibited TRPM6 and TRPM7 currents
(sFig. 2). The inhibitory effects of U-73122 could be caused by direct
inhibition of the channels, or through the partial agonist effect of
U-73122 on PLC35.
Although HM1 cells have much lower expression of endogenous
TRPM7 (, 200 pA)36, to ensure that the CCh inhibited current is
indeed TRPM6 current, we applied 200 mM 2-APB before applica-
tion of CCh. We have previously demonstrated that 200 mM 2-APB
can completely inhibit TRPM7 currents, but fully potentiate TRPM6
currents33. As shown in Fig. 1C, 2-APB at 200 mM markedly
enhanced current amplitude by 100%, indicating that the currents
recorded in HM1 cells that were largely inhibited by CCh were
indeed TRPM6 currents.
Stimulation of the M1 receptor by CCh can activate PLC-b which
hydrolyzes PIP2 and generates diacylglycerol (DAG) and inositol
1,4,5-trisphosphate (IP3). We hypothesized that depletion of PIP2
inactivates TRPM6 channel activity, similar to the effects of PIP2
on TRPM734. Indeed, inclusion of DAG or IP3 in the pipette solution
did not influence TRPM6 current amplitude (data not shown).
Furthermore, we applied GTPcS in the pipette solution to mimic
the effect of M1 receptor activation by CCh. Consistent with the
effects of CCh on TRPM6 current in HM1 cells, GTPcS inhibited
TRPM6 currents in a dose-dependent manner (Figure 1E–F). These
results indicate that Gq linked receptor activation can inhibit
TRPM6 channel activity. Since GTPcS activates several downstream
pathways, we further tested the effects of activators of PKC and
cAMP on TRPM6 currents. As shown in sFig. 3, application of
5 mM Foskolin to activate cAMP did not change TRPM6 current
amplitude, consistent with previous report37. Perfusing the cells with
PDBu to activate PKC could not produce significant changes on
TRPM6 currents either. Furthermore, GTPcS included in the pipette
solution could indeed cause PIP2 deletion, as detected by the trans-
location of the PH-GFP, an indicator of PIP2. (sFig. 3C–D). These
results suggest that GTPcS elicited inactivation of TRPM6 is mainly
through PLC activation induced PIP2 hydrolysis.
Direct removal of PIP2 by chemical translocation of 5-phosphatase
for PtdIns(4,5)P2 to the plasma membrane inactivates TRPM6. To
determine whether depletion of PIP2 underlies the mechanism by
which TRPM6 is inhibited by M1 receptor activation, we first applied
a chemical dimerization system induced by Rapamycin (Rap) to
deplete PIP2. The membrane-localized Rap binding protein PM-
FRB and the fluorescent cytoplasmic enzyme construct FKBP-5-phos-
phatase (5-ptase) were co-transfected with TRPM6 into HM1 cells.
Application of the chemical inducer Rap will recruit 5-ptase to the
Figure 1 | TRPM6 current is inhibited by CCh stimulation of the M1
receptor. (A) A representative recording in HM1 cells transfected with
TRPM6. Currents were elicited by 100 ms voltage ramps ranging from
2100 to 1100 mV. Application of 200 mM CCh to activate M1 receptor
completely inhibited TRPM6 current. (B) Time-dependent changes of
outward TRPM6 current measured at 1100 mV before and after 200 mM
CCh application. (C) Potentiation of the currents by 2-APB was used to
confirm that the recordings were TRPM6 currents. (D) Mean current
densities of TRPM6 before and after CCh (n510, * p,0.05). (E)
Representative traces of TRPM6 currents recorded from different cells
using pipette solution with or without 1 mM GTPcS. (F) Concentration-
dependent effects of GTPcS on TRPM6. Currents recorded at various
GTPcS concentrations were normalized to the current recorded without
GTPcS in the pipette solution. Best fit of the dose-response curve yielded
IC50510.1 mM (n55–9 cells for each GTPcS concentration).
www.nature.com/scientificreports
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plasma membrane, thereby rapidly and irreversibly convert PIP2 to
PI(4)P by removing the 59 position phosphate at the triphosphoino-
sitol ring (Fig. 2A)38, 39. As shown in Fig. 2, in the cells co-expressing
TRPM6 with 5-ptase and the anchor protein FBR, application of
10 mM Rap substantially reduced TRPM6 current amplitude
(Fig. 2B–C) with an average inhibition of 90%6 9% (Fig. 2D). Rap
(10 mM) did not produce noticeable effects on TRPM6 current in the
cells without over-expression of 5-ptase and anchor protein FRB
(Fig. 2E–G). Moreover, when TRPM6 was co-transfected with FRB
and the mutant 5-ptase (D281A)38, application of 10 mMRap failed to
reduce TRPM6 current amplitude (sFig. 4). Thus, the results in Fig. 2
demonstrate that activation of 5-ptase to deplete PIP2 can fully
inactivate TRPM6 channels, providing strong evidence that PIP2 but
not PI(4)P is required for TRPM6 channel function.
Simultaneous changes of PIP2 level and TRPM6 channel activity.
The membrane PIP2 levels can be modulated by a variety of stimuli
and intracellular events. A recently identified voltage-sensitive phos-
phatase from Ciona intestinalis (Ci-VSP) possesses voltage-sensitive
phosphatase activity40. Ci-VSP can convert PIP2 to PI(4)P upon
depolarization, but does not have phosphatase activities at hyper-
polarized voltage40, 41. Co-transfection of TRPM6 and Ci-VSP
provides us an opportunity to change membrane PIP2 levels using
TRPM6 recording protocol (voltage ramp) without applying addi-
tional chemicals. Cells were held at 260 mV for 3 min to allow
the pipette solution to fully dialyze into the cells. Then, a standard
voltage ramp protocol ranging from 2120 mV to 1100 mV was
used to activate Ci-VSP and to record TRPM6 currents (Fig. 3A).
As shown in Fig. 3, TRPM6 current was rapidly decreased in the cells
co-expressing TRPM6 and Ci-VSP (Fig. 3B, D–E); whereas, in
cells transfected with TRPM6 alone, TRPM6 current remained
unchanged (Fig. 3C–D, F), indicating that depolarization induced
dephosphorylation of PIP2 by Ci-VSP inhibited TRPM6 channel
activity. These results provide further evidence that PIP2 hydrolysis
inactivates TRPM6.
To determine the correlation of PIP2 hydrolysis and TRPM6 chan-
nel activity, we simultaneously monitored the changes of membrane
PIP2 levels and TRPM6 current amplitude. A PtdIns(4,5)P2 reporter,
PLCd1-PH-GFP construct, was co-transfected with TRPM6 and
Ci-VSP to the cells. PH-GFP is localized in the cell membrane by
binding to PIP2, and can be released to the cytosol when PIP2 is
hydrolyzed. We monitored the translocation of PH-GFP and
recorded TRPM6 current simultaneously in the same cells. In the
co-transfected cells, TRPM6 current was rapidly inhibited in the first
Figure 2 | Membrane tethering of type IV 5-ptase reduces membrane PIP2 and suppresses TRPM6 current. (A) Schematic diagram demonstrating
how the rapamycin (Rap) inducible PIP2 specific phosphatase system works. (B) Representative recordings of TRPM6 before and after Rap application
in cells transfected with GFP-TRPM6, FKBP-Inp54p and Lyn-FRB. (C) Time course of TRPM6 inhibition by perfusing 10 mM Rap. (D) Average
inhibition of TRPM6 by 10 mM Rap (n512) in cells transfected with TRPM6, FKBP-Inp54p and Lyn-FRB. (E) Representative recordings of TRPM6
before and after Rap application in cells transfectedwith TRPM6 alone. (F) Time-dependent changes of TRPM6before and after 10 mMRap in cells shown
in (E). (G) Mean current densities of TRPM6 before and after Rap. Rap did not produce inhibition on TRPM6 in cells transfected with TRPM6 alone.
www.nature.com/scientificreports
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20 s, and almost completely inhibited at 200 s; whereas, in the
TRPM6 only transfected cells, current amplitude was barely changed
over the time course of 200 s recording (Fig. 3D). Meanwhile, the
membrane fluorescence representing translocation of PH-GFP sig-
nificantly decreased in the first 20 s, and slowly disappeared over the
time course of 200 s (Fig. 3G–H). The time-dependent inhibition of
TRPM6 current amplitude exhibited a similar kinetics to that of
translocation of PH-GFP. The time constant was 36.566.9 s for
TRPM6 inhibition, and for PH-GFP translocation was 24.26 2.5 s
(Fig. 3H). The kinetics of PIP2 hydrolysis by activation of Ci-VSP
was slower than previously reported42, probably due to the ramp
protocols used in our experiments. Nevertheless, the well-correlated
kinetics of TRPM6 inactivation and PIP2 hydrolysis (Fig. 3H) indi-
cates that TRPM6 channel inactivation is caused by the decrease of
PIP2 levels. Indeed, including water soluble PIP2 (DiC8-PIP2) in the
pipette solution significantly reduced the inactivation speed of
TRPM6 caused by PIP2 hydrolysis in the TRPM6 and Ci-VSP co-
transfected cells (sFig. 5), supporting the notion that PIP2 is neces-
sary for TRPM6 channel activation.
Depletion of PIP2 inactivates TRPM6 channel activity in perfo-
rated-patch. Since the above results were obtained by whole-cell
configuration, to eliminate any interference of pipette solution to
the effects of PIP2 on TRPM6 activity, we applied perforated-patch
to determine the effects of PIP2 hydrolysis on TRPM6. As shown in
sFig. 6, in the cells co-transfected with TRPM6 andCi-VSP, there was
substantial TRPM6 current recorded by perforated-patch, albeit the
current amplitude being smaller than that of whole-cell current
amplitude. TRPM6 current was readily reduced by depolarization
which activated Ci-VSP to hydrolyze PIP2, further confirming that
PIP2 is essential for TRPM6 channel activity. The effects of deletion
of PIP2 in perforated patches were also observed in TRPM7 trans-
fected cells (sFig. 7).
Putative PIP2 interacting residues of TRPM6. PIP2 regulates ion
channel function by binding to specific residues43. To understand the
mechanism by which PIP2 activates TRPM6, we mutated the posi-
tively charged residues equivalent to those of TRPM8, which have
been shown to be responsible for PIP2 modulation44. We created
single and double mutants as shown in Fig. 4, and tested channel
function of these mutants. The current amplitude of K1085Q and
R1088Q mutants was much smaller than that of WT TRPM6
(Fig. 4B, E), yet they can be potentiated by 2-APB (Fig. 4C–D),
indicating that the recorded currents from K1085Q and R1088Q
transfected cells were TRPM6. The reduced current amplitude of
the mutants could be the consequence of disrupted interaction of
PIP2 with the putative binding residues. Interestingly, the mutation
of Lys to Glu (K1098Q) completely abolished TRPM6 channel acti-
vity (Fig. 4E), suggesting that Lys1098 may bemore crucial for TRPM6
channel activity than Lys1085 and Arg1088. The loss-of-function
mutant K1098Q has no response to 2-APB stimulation (Fig. 4F).
Furthermore, although both K1085Q and R1088Q mutants pro-
duced small currents, double mutation by neutralizing both Lys1085
and Arg1088 abolished channel function completely (Fig. 4E–F). Like
K1098Q, the non-functional double mutant K1085Q/R1088Q could
not be reactivated or potentiated by 2-APB, suggesting that the
effects of 2-APB on TRPM6 depend on the presence of PIP2 and
the availability of the interaction between PIP2 and TRPM6. This
hypothesis is supported by the results that 2-APB could not poten-
tiate TRPM6 after the channel is completely inactivated by PIP2
depletion induced by Ci-VSP activation (sFig. 8).
To determine whether mutations disrupt plasma membrane
localization leading to dysfunctional channels, we measured plasma
membrane protein and total protein levels of TRPM6 and the
mutants (Fig. 5). GADPH was used as a negative control for the
plasma membrane protein. The ratios of plasma membrane/total
protein of K1085Q, R1088Q, K1098Q, and K1085Q/R1088Q were
not significantly different from that of WT TRPM6 (Fig. 5B), indi-
cating that mutations of the positively charged residues in the TRP
domain, but not the expression or trafficking of the channel proteins,
disrupted TRPM6 channel function.
PIP2 regulates single channel activities in excised patches of
TRPM6 and its mutant. To examine directly the effects of PIP2 on
Figure 3 | Simultaneous monitoring of PIP2 depletion and TRPM6
inactivation. (A) The protocol for activation of Ci-VSP and recording of
TRPM6 currents. Cells were held at 260 mV to allow dialysis of pipette
solution without activation of Ci-VSP. Voltage Ramp ranging from 2120
to 1100 mV was applied to activate Ci-VSP and record TRPM6 currents.
(B–C) Representative traces recorded before and after activation of Ci-VSP
in cells transfected with TRPM6 and Ci-VSP (B) and TRPM6 alone (C).
(D) Time-dependent changes of TRPM6 outward current measured at
1100 mV in cells transfected with TRPM61Ci-VSP and TRPM6 alone.
(E–F) Normalized currents before and after depolarization from cells with
TRPM61Ci-VSP transfection (E) and with TRPM6 transfection alone (F)
(n58 for each group). (G) Representative GFP-PH domain sub-cellular
location at different time points upon depolarization. Cells were
co-transfected with GFP-PH, Ci-VSP and TRPM6. (H) Kinetics of cytosol
fluorescence increment and TRPM6 current inhibition. The intensity of
fluorescence and current amplitude of TRPM6 at each time-point were
normalized to the initial values, respectively. The time constants obtained
by mono-exponential fit were 24.26 2.5 s for PH-GFP translocation, and
36.566.9 s for TRPM6 inactivation.
www.nature.com/scientificreports
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channel activity, TRPM6 single channel currents were recorded at
250 mV in inside-out patches in the DVF solution as shown in
Fig. 6A. Similar single channel currents were not observed in
mock-transfected cells. The slope conductance calculated based
on single channel current amplitude at 250 mV (3.9960.3pA),
280 mV (6.760.8pA), and 2120 mV (9.861.1pA) was 82.7 pS
(n54), which is indistinguishable from the signature conductance
of TRPM6 (83.6 pS)33. To further confirm that the recorded currents
were TRPM6 currents, we applied 2-APB to the excised patches.
Similar to the effects of 2-APB on macroscopic TRPM6 currents,
we observed that 2-APB increased TRPM6 channel activity (Data
not shown). Like other PIP2 activated channels such as TRPM734 and
TRPM844, single channel activities of TRPM6 rundown in excised
patches (Fig. 6A), presumably caused by depletion of PIP234, 44. After
rundown, application of PIP2 (DiC8-PIP2) recovered TRPM6 chan-
nel activity by almost 80% (Fig. 6A, D), indicating that PIP2 is suf-
ficient to activate TRPM6. In contrast to the WT TRPM6 single
channel activity, the putative PIP2 binding residue mutant R1088Q
exhibited extremely low open probability (Fig. 6B–C), suggesting
that neutralization of the positive charges of the putative PIP2
binding sites might have impaired channel activity. Moreover, after
rundown, application of 10 or 50 mM PIP2 to the excised patches of
R1088Q only recovered the channel activity by 10%, suggesting that
the activation of R1088Q by PIP2 is significantly decreased in com-
parison withWT TRPM6. These results imply that R1088 is likely to
be involved in the interaction of TRPM6 and PIP2.
The putative PIP2 binding residues are essential TRPM7 channel
activity.TRPM6 and TRPM7 are the closest homologues with a num-
ber of similar and distinctive properties17, 18, 33, 45. Previous studies have
shown that depletion of PIP2 inactivates TRPM7, yet the PIP2 binding
siteswere not determined34, 46. Thus,wemutated the positively charged
residues equivalent to those of TRPM6 in the TRP domain (Fig. 4A).
Unlike TRPM6, all the single mutants of TRPM7 exhibited channel
activity (Fig. 7A–B), although the current amplitude of K1112Q was
significantly smaller than that of WT TRPM7. The double-mutant
K1112Q/R1115Q and the triple mutant K1112Q/R1115Q/K1125Q,
however, completely lost channel function. Moreover, current
Figure 4 | PIP2 binding sites of TRPM6. (A) Alignment of the TRP domain of TRPM6, TRPM7 and TRPM8. The highlighted residues in TRPM8
are the PIP2 binding sites. (B) Representative traces ofWT-TRPM6 andmutants K1085Q, R1088Q, and K1098Q. (C–D) Effects of 2-APB on themutants
K1085Q and R1088Q. (E) Normalized mean current density of TRPM6mutants in comparison withWT TRPM6 (n510 *p,0.05; ** P,0.01). Mutants
K1098Q and the double mutants K1085Q/R1088Q did not produce any current. (F) Average changes of current amplitude by 2-APB (200 mM). 2-APB
did not have any effect on the non-functional mutants K1098Q and K1085Q/R1088Q.
www.nature.com/scientificreports
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amplitude of the cells transfected with K1112Q/R1115Q or K1112Q/
R1115Q/K1125Q (Fig. 7A) was even smaller than that of mock-trans-
fected cells, suggesting that the loss-of-function mutants K1112Q/
R1115Q and K1112Q/R1115Q/K1125Q behave as a dominant-
negative to the endogenous TRPM7 channel. Given that PIP2 has
been shown to be necessary and sufficient for TRPM7 channel
activation, it is likely that the conserved positively charged residues
in the proximity of the TRP domain are essential for PIP2 and
TRPM7 interaction.
Since PIP2 is the only activator for TRPM7, to further confirm that
double mutant and the triple mutant of TRPM7 are indeed loss-of-
function mutants, we tested the effects of NH4Cl on these mutants.
Perfusion of NH4Cl has been proposed to increase intracellular
pH thereby releasing PIP2 sequestered by other cations such as H1,
Mg21, or other polyvalent cations46. For these experiments, we
included 1 mM free Mg21 in the pipette solution. As shown in
Fig. 7C, after perfusion with 30 mMNH4Cl, K1112Q current ampli-
tude was increased by 5-fold; whereas the triple mutant had no
response to NH4Cl, suggesting that the double mutant (data not
shown) and the triple mutant are nonfunctional mutants.
PIP2 depletion abolishes Mg21 currents and Mg21 influx through
TRPM6. Next we examined whether PIP2 depletion affects Mg21
influx through TRPM6. As shown in Fig. 8A,Mg21 currents recorded
using isotonic Mg21 external solution were significantly increased
by 200 mM 2-APB. After depletion of PIP2 in cells co-transfected
with TRPM6 and Ci-VSP, the Mg21 current was fully inhibited
(Fig. 8A–B). Similar results were observed using CCh and GTPcs
to delete PIP2 (data not shown). We further measured Mg21 influx
through TRPM6 before and after PIP2 depletion. The membrane
permeable Mg21 indicator KMG104-AM was used to measure
changes of intracellular Mg21 induced by perfusing cells with iso-
tonic Mg21 solution. As shown in Fig. 8 C, significant increase in the
normalized fluorescence intensity (F/F0) was induced by perfusion of
isotonic Mg21 in TRPM6-transfected cells in comparison with the
non-transfected cells. Moreover, the change of Mg21 influx was
largely diminished in the cells perfused with 200 mM CCh in DVF
and isotonicMg21 solutions to hydrolyze PIP2. These results indicate
that hydrolysis of PIP2 can induce TRPM6 inactivation and abolish
TRPM6 mediated Mg21 influx, suggesting that activation of PLC by
Gq-linked receptors may play an pivotal role in regulating Mg21
homeostasis by controlling TRPM6 channel activity.
TRPM6 kinase domain interacts with PLC, but the interaction is
not required for PLC induced TRPM6 inactivation. As shown in
previous studies, the TRPM7 channel kinase domain interacts with the
C2 domain of PLC, especially PLC-b2 isoform34. Since TRPM6 and
TRPM7 share high homology, we tested whether the TRPM6 kinase
domain binds to the PLC isoforms. As shown in sFig. 9, the TRPM6
kinase domain primarily binds to the PLC b isoforms, including
PLCb1-3. Unlike GST-M7 KIN, GST-M6 KIN did not pull-down
the PLC-d1. This result suggests that the kinase domain of TRPM6
and TRPM7 preferentially interact with various PLC isoforms.
To understandwhether interaction of the kinase domainwith PLC
is necessary for PLC activation induced inhibition of TRPM6 and
TRPM7, we made truncation mutants of TRPM6 (M6-Dkinase)
Figure 5 | Plasma membrane expression of WT TRPM6 and the putative PIP2 binding-site mutants. (A) Western-blot (with GFP antibody) detection
of proteins of theWT andmutants in the plasmamembrane portion and in total lysate. GADPHwas used as a negative control for the plasmamembrane
protein. (B) Mean relative expression level of WT TRPM6 and the mutants in the plasma membrane versus total protein. No statistically significant
difference was observed (n53).
www.nature.com/scientificreports
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and TRPM7 (M6-Dkinase) by deleting the kinase domain at the
C-terminus. Currents recorded from M6-Dkinase were verified by
response to 2-APB (sFig. 9 C). Since we have shown that GTPcS
inactivates TRPM6 mainly through activation of PLC pathway, we
used GTPcS to activate PLC. As shown in sFig. 9 C–F, inclusion of
GTPcS in the pipette solution markedly inhibited M6-Dkinase and
M7-Dkinase currents, indicating that the interaction between kinase
domain and the PLC is not necessary for the PLC activation induced
TRPM6 and TRPM7 channel inactivation. Similar results were
also obtained using CCh to induce inactivation of M6-Dkinase
and M7-Dkinase expressed in the HM1 cells. CCh (200 mM) com-
pletely inhibited M6-Dkinase and M7-Dkinase currents (n55 for
each group).
Discussion
We reported several new findings here. First, we demonstrated that
PIP2 is necessary and sufficient for TRPM6 activation. Second, we
identified that the positively charged residues in the TRP domain are
likely to participate in TRPM6 and PIP2 interactions. Third, we
found that TRPM6 interacts with PLC isoforms, but the interaction
is not necessary for PLC induced TRPM6 or TRPM7 inactivation.
Fourth, inactivation of TRPM6 by PIP2 depletion eliminates Mg21
currents andMg21 influx, suggesting that PIP2 regulatesMg21 home-
ostasis by controlling TRPM6 gating. Our results indicate that
regulation of TRPM6 by PIP2 through PLC activation pathway
may serve as an important pathway to gate TRPM6 and control
Mg21 homeostasis.
TRPM6 plays a vital role inMg21 homeostasis, as demonstrated by
the mutations of TRPM6 that cause HSH9, 10. Although it has been
reported that TRPM6 expression can be regulated by various factors,
including estrogen26, 47, AngII27, acidosis/alkalosis conditions28,
immunosuppressant tacrolimus29, diuretics Thiazide30, and EGF31,
how TRPM6 is gated has remained elusive. Here we provided several
lines of evidence demonstrating that TRPM6 gating is controlled by
cellular PIP2 levels. Activation of PLC-coupled M1 receptor by CCh
completely suppressed TRPM6 current amplitude (Fig. 1). This
result is supported by pharmacological activation of PLC induced
suppression of TRPM6 (Fig. 1E–F). Using the recently developed
approach for the study of phosphoinositide signaling, which is based
on the rapamycin-induced heterodimerization of the rapamycin
(Rap) binding domain of mTOR (FRB) and FKBP12 (Fig. 2)38, 39,
we showed that application of Rap rapidly and fully inactivated
TRPM6 channel activity (Fig. 2). Rap induced translocation of
over-expressed type-IV 5-phosphatase (5-Ptase) specifically hydro-
lyzes PIP2 without involvement of other signaling factors. Thus, Rap
induced inactivation of TRPM6 strongly indicates that PIP2 is
required for TRPM6 channel function. This conclusion was further
supported by the fact that TRPM6 can be inactivated by Ci-VSP
elicited PIP2 depletion (Fig. 3). Furthermore, application of PIP2
in excised patches can reactivate TRPM6 after rundown (Fig. 6).
Thus, it appears that PIP2 is necessary and sufficiently for TRPM6
channel activity.
PIP2 regulates a large number of ion channel functions by inter-
acting with specific residues or domains43. However, due to the lack
of crystal structure information of most of ion channels, putative
PIP2 interacting sites are usually predicted based on direct binding
experiments with PIP2, or changes of PIP2 affinity evaluated by
channel functions between Wide-Type and mutants43. Positively
charged residues at both N- and C-termini have been shown to be
putative PIP2 interacting domains43, 48–50. Rohacs and colleagues
demonstrate that the basic residues within the TRP domain are likely
the putative PIP2 binding sites for TRPM8, TRPV5 and TRPM544.
Nilius and colleagues found that a PH-like domain at the more distal
C-terminal region of TRPM4 may be involved in PIP2-dependent
Figure 6 | Effects of PIP2 on channel activities of TRPM6 and its mutant in the inside-out patches. (A) Representative recordings ofWT TRPM6 single
channel currents in an inside-out patch at -50 mV recorded in divalent free solution (DVF). PIP2 (DiC8-PIP2) at 10 mM was applied to the patch after
completely rundown of channel opening. (B) Single channel currents of R1088Q recorded at 250 mV right after formation of excised patch, after
rundown, and upon application of 10 mMPIP2. (C)Average open probability of TRPM6 (n58) andR1088Q (n57) before and after completely rundown.
(D) Percentage of channel open probabilities rescued by 10 mMPIP2 after rundown of TRPM6 and R1088Q. The effect of DiC8-PIP2 was reversible and
reproducible in the same patches.
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regulation51. We mutated the conserved basic residues at the TRP
domain of TRPM6, which are equivalent to the putative PIP2-bind-
ing sites of TRPM844. The mutants K1085Q and R1088Q displayed
largely diminished channel activity, whereas K1098Q and the double
mutant K1085Q/R1088Q completely lost channel function. Since
PIP2 is the only activator of TRPM6, the decreased channel function
of themutants suggests that themutations disrupt TRPM6 activation
by PIP2.Moreover, it seems thatmutant R1088Qhas reduced activity
by PIP2, as evidenced that PIP2 at 10 mM recovered channel
activity by 80% of WT, but only 10% of R1088 (Fig. 6). Mutation
of the conserved residues of TRPM7 also markedly reduced channel
activity. Therefore, it is likely that the basic residues at the TRP
domain may participate in channel-PIP2 interactions. Further
studies are required to confirm whether the positively charged resi-
dues at the TRP domain are PIP2 binding sites. Excitingly, Hansen
and colleagues have recently discovered the structure basis of inter-
action between PIP2 and Kir2.252. Putative PIP2 binding residues at
the cytoplasmic domain predicted by previous mutagenesis studies43
are proven to interact with PIP2. A conserved non-specific phospho-
lipid binding region is also shown to constitute the PIP2-binding
interface with the cyloplasmic domain for PIP2 binding. Thus, it is
conceivable that the predicted PIP2 binding residues at the TRP
domain may be proven to be the PIP2 binding sites in the future.
Like TRPM734, TRPM6 kinase domain interacts with different
PLC isoforms (sFig. 9). However, we found that the interaction of
M6-KIN and M7-KIN with PLCs is not required for modulation of
TRPM6 and TRPM7 by PLC activation, as evidenced by the fact that
the truncation mutants of TRPM6 and TRPM7 without the kinase
domain can also be inactivated by PLC activation (sFig. 9). Although
it is not necessary for PLC-induced regulation on TRPM6 and
TRPM7, given the different distribution profiles of the PLC iso-
forms53, 54, the interaction or co-localization of TRPM6 and
TRPM7 with different isoforms of PLC may underlie different, yet
to be determined physiological/pathological functions.
Our results seem to indicate that TRPM6 is exclusively gated by
PIP2. The loss-of-function mutants of putative PIP2 binding sites
cannot be potentiated by 2-APB (Fig 4). Similarly, inactivated
TRPM6 by completely deletion of PIP2 has no response to 2-APB
(sFig. 8). PIP2 may also be the exclusive activator of TRPM734. The
important role of PIP2 on TRPM7 activation was demonstrated in
200234, and the conclusion was supported by other studies46, 55.
However, Takezawa and colleagues reported that activation of PLC
through endogenous M1-muscarinic receptors has little effect on
TRPM7 over-expressed in HEK cells56. Rather, they suggested that
cAMP enhances TRPM7 activity. It was reported later that failure of
inhibition of TRPM7 by CCh using endogenous M1 receptor56 was
probably due to the minor PIP2 breakdown by limited endogenous
M1 receptor57. The effects of cAMP on TRPM7 activation56 was not
observed by Langeslag and colleagues57. Indeed, Langeslag and
colleagues elegantly demonstrated a positive correlation between
TRPM7 channel activity and PIP2 level57, in agreement with the
results that TRPM7 activity requires PIP2 as shown in Fig. 7 and as
previous reported34. However, under perforated-patch configura-
tion, Langeslag and colleagues observed that Bradykinin induced a
transient inhibition of TRPM7 currents57, because PIP2 levels were
quickly recovered in N1E-115 cells. They therefore suggested that
PLC-coupled agonists activates TRPM757. Although it was unclear
why PIP2 levels were quickly recovered under the perforated-patch
configuration57, it is plausible that other signaling pathways were
involved in PIP2 synthesis under their experimental conditions.
Nevertheless, using perforated patch configuration, we demon-
strated that activation of the voltage-sensitive Ci-VSP by depolariza-
tion can completely inhibit both TRPM6 (sFig. 6) and TRPM7
(sFig. 7) channel activities. Therefore, it seems that PIP2 is a strong
and exclusive activator of TRPM6 and TRPM7.
Mg21 permeation through TRPM6 was substantially enhanced
when TRPM6 channel activity was increased by 2-APB. However,
after depletion of PIP2 by CCh, Mg21 current and Mg21 influx
were largely blocked (Fig. 8). This PLC-activation induced Mg21
regulation may produce physiological/pathological significance.
In the distal convoluted tubule (DCT) where TRPM6 is highly
expressed, Ca21/Mg21-sensing receptors (CaSR) are also abundantly
expressed58. Stimulation of CaSR activates PLC, especially theb and c
isoforms59, which thereforemay influence themagnesium re-absorp-
tion by regulation of TRPM6 channel function. Several peptide
hormones such as PTH, calcitonin, glucagon, and AVP enhance
magnesium reabsorption in the DCT60. Groenestege and colleagues
Figure 7 | Mutation of the putative PIP2 binding residues of TRPM7
disrupts channel function. (A) Representative traces of WT TRPM7 and
its mutants. The double mutant K1112Q/R1115Q (DM) and the triple
mutant K1112Q/R1115Q/K1125Q did not produce currents. (B) Mean
current densities of the WT and its mutants (n58–13, *p,0.05). (C)
Effects of NH4Cl onK1112Q, and triplemutant K1112Q/R1115Q/K1125Q
(TM) were tested by using pipette solution containing 1 mM free Mg21.
Perfusion of 30 mMNH4Cl can increase intracellular pH thereby releasing
PIP2 sequestered byMg
21, thus, the effects of PIP2 on the channel activity is
manifested. NH4Cl significantly increase the current amplitude of
K1112Q, but failed to induce any change in the DM and TM transfected
cells, indicating that the double mutant K1112Q/R1115Q and the triple
mutant K1112Q/R1115Q/K1125Q have no ability to sense the changes of
PIP2 levels.
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very nicely showed that EGF regulates Mg21 re-absorption by regu-
lation of TRPM6 trafficking to the cell membrane37, 47. A mutation of
the EGF gene encoding pro-EGF causes renal Mg21 wasting37, 47. As
EGF can also activate PLC-c, leading to PIP2 depletion, theremight a
fine-tuned regulation regarding how EGF modulates TRPM6.
Nonetheless, it will be of great interest to investigate whether and
how the other Mg21 regulating hormones may regulate the Mg21
homeostasis through Mg21 gate-keeper TRPM6.
In conclusion, we have demonstrated at various levels that PIP2 is
required for TRPM6 channel activity, and that disruption of the
putative PIP2 binding sites results in dysfunctional or non-functional
TRPM6 channels. As TRPM6 is considered as a Mg21 gate-keeper,
understanding the critical role of PIP2 in TRPM6 channel function
may facilitate our understanding of howMg21 contributes to physio-
logical/pathological processes, as well as the development of thera-
peutic approaches for hypomagnesemia treatment.
Methods
Molecular biology. TRPM6 plasmid (pCINeo/IRES-GFP) was kindly provided by
Dr. Joost G. J. Hoenderop. Mutations of TRPM6 and TRPM7were made by using the
QuickChange Site-Directed Mutagenesis Kit (Stratagene) following the manufac-
ture’s instruction. The primers sequences will be available upon request.
Electrophysiology. Whole-cell and single-channel currents were recorded using an
Axopatch 200B amplifier. Data were digitized at 5 or 10 kHz, and digitally filtered off-
line at 1 kHz. Patch electrodes were pulled from borosilicate glass and fire-polished to
a resistance of,3 MV when filled with internal solutions. Series resistance (Rs) was
compensated up to 90% to reduce series resistance errors to ,5 mV. Cells with Rs
bigger than 10 MV were discarded21.
For whole cell current recordings, voltage stimuli lasting 250 ms were delivered at
1 s intervals, with either voltage ramps or voltage steps ranging from 2120 to
1100 mV. A fast perfusion system was used to exchange extracellular solutions, with
complete solution exchange achieved in about 1 to 3 s32. The internal pipette solution
for TRPM6 or TRPM7 whole cell current recordings contained (in mM) 145 Cs-
methanesulfonate (CsSO3CH3), 8 NaCl, 10 EGTA, and 10 HEPES, with pH adjusted
to 7.2 with CsOH. Ca21 was adjusted to various concentrations based on calculation
using MaxChelator32. The standard extracellular Tyrode’s solution for whole cell
recording contained (mM): 145 NaCl, 5 KCl, 2 CaCl2, 10 HEPES and 10 glucose;
pH was adjusted to 7.4 with NaOH. Divalent-free solution (DVF) contained
(mM) 145 NaCl, 20 HEPES, 5 EGTA, 2 EDTA and 10 glucose, with estimated free
[Ca21], 1 nM and free [Mg21] <10 nM at pH 7.4. MaxChelator was used to cal-
culate free Ca21 and free Mg21 concentrations.
Single channel currents were recorded in inside-out patches. The extracellular DVF
solution contained (mM) 145 Na-methanesulfonate (NaSO3CH3), 20 HEPES, 5
EGTA, 2 EDTA, and 10 glucose, with pH adjusted to 7.4; internal solution contained
(mM) 145 CsSO3CH3, 8 NaCl, 10 EGTA, and 10 HEPES, with pH adjusted to 7.2.
Rapamycin induced PIP2 depletion. The two plasmids PM-FRB-CFP and mRFP-
FKBP-5-ptase were kindly provided by Tamas Balla. The phosphatase dead mutant
CF-InP-D281A was kindly provided by Dr. Thomas Mayer. PM-FRB-CFP and
mRFP-FKBP-5-ptase were co-transfected with TRPM6 to the cells, and 10 mM
rapamycin was applied to induce 5-ptase translocation to deplete PIP2. In the case of
testing phosphatase dead mutant, PM-FRB-CFP and CF-InP-D281A were co-
transfected with the channel to HEK293 cells.
Western blot. The HEK 293 cells transfected with TRPM6 were allowed 48 hours to
express protein. Cell lysate was used to blot with anti-GFP antibody (Neuromab). The
ECL chemiluminescence was detected and captured by FUJI LAS-3000 Imaging
System.
Membrane protein detection. HEK 293T cells were transfected with WT TRPM6
(GFP-tagged) or mutants. After 48 h, cell membrane protein biotinylation was per-
formed with Pierce Cell Surface Protein Isolation Kit (catalogue no. 89881). Briefly,
monolayers of cells were washed with cold PBS and then incubated with Sulfo-NHS-
SS-Biotin solution at 4uC for 30 min. After incubation, the reaction was quenched,
and the cells were washed 3 times with TBS solution (50 mM tris, 150 mM Nacl,
pH 7.6), followed by lysing procedure for 30 min on ice. After centrifugation for
10 min at 16,000 g, supernatant passed a sufficient amount of NeutrAvidin Agarose
(Pierce Biotechnology), and the flow-through was kept as cytosol portion. Agarose
beads with protein were washed 3 times and then boiled with 1X SDS buffer con-
taining 50 mMDTT at 95uC, and supernatant containing releasedmembrane protein
was kept for analysis by Western blotting.
Ratio Ca21 imaging experiments. Cells were plated on 25 mm glass coverslips
loaded with 1 mM Fura-2 for 20 minutes. Non-incorporated dye was washed away
using a HEPES-buffered Saline Solution (HBSS) containing (in mM) 20 HEPES, 10
glucose, 1.2 MgCl2, 1.2 KH2PO4, 4.7 KCl, 140 NaCl, 1.3 Ca21 (pH 7.4). Ca21 influx
was measured by perfusing the cells with Tyrode’s solution containing 20 mM Ca21
after the cells were perfused with nominal Ca21 andMg21 free solution for 2 minutes.
Ionomycin (Iono) at 1 mMwas applied as internal control. Fluorescence intensities at
510 nm with 340 nm and 380 nm excitation were collected at a rate of 1 Hz using
CoolSNAP HQ2 (Photometrics) and data were analyzed using NIS-Elements
(Nikon)21. The 3405380 nm ratio in the presence of 20 mM Ca21 was normalized to
that of 1 mM Ionomycin (Iono) elicited Ca21 signal.
Detection of Mg21 influx. HM1 cells were cultured on poly-L-lysine-coated cover
slips in DMEM-F12 medium at 37uC. Cells were then loaded with KMG104-AM dye
at a final concentration of 20 mM for 30 min in standard tyrode solution without
added magnesium. Tyrode solution contained: 135 mM NaCl, 4 mM KCl, 10 mM
glucose, 10 mM HEPES, 2 mM CaCl2, pH 7.4. Fluorescence intensities at 510 nm
with 488 nm excitation were collected very 10 s using CoolSNAP HQ2
(Photometrics) and data were analyzed using NIS-Elements (Nikon). F0 refers to the
initial fluorescence recorded at t5 0 s. Mg21 influx was measured by perfusing the
cells with isotonic Mg21 solution containing (mM) 120 MgCl2, 10 Hepes, 10 glucose,
and pH was adjusted to 7.4.
GST-pulldown purification assay.HEK-293T cells in 10-cm dishes were transfected
using LipofectAMINE 2000 (Life Technologies, Rockville,MD)with 10 mg expression
vector containing either PLC-b1–4, PLC-c1, or GFP–PLC-d1 cDNAs. After 48 h,
cells were lysed in 2 ml of RIPA buffer (50 mMTris-HCl at pH 7.4, 150 mM sodium
chloride, 1 mM EDTA, 1% IGEPAL CA-630, 0.5% (w/v) deoxycholate, 0.1% (w/v)
SDS and 10 mM iodoacetamide). GST–TRPM6 kinase, GST-TRPM7 kinase or
GST alone was expressed and purified with glutathione-4B Sepharose beads. Bound
GST–kinases, GST or beads were incubated with lysates containing various PLCs for
12 h. Bound proteins were washed three times in RIPA buffer, eluted by boiling in
23SDS–polyacrylamide gel electrophoresis (PAGE) sample buffer and then sepa-
rated by SDS–PAGE. PLC-b1–4 and PLC-c1 were detected by western blotting with
the following specific anti-PLC antibodies from Santa Cruz Biotechnology (Santa
Cruz, CA): PLCb1(G-12), PLCb2(Q-15), PLCb3(C-20), PLCb4(C-18),
PLCc1(E-12). An anti-GFP antibody (Clontech) was used to detect GFP-tagged
PLC-d1. A horseradish peroxidase-linked antibody to rabbit Ig (Amersham
Pharmacia Biotech, Piscataway, NJ) and SuperSignal West Dura substrate was used
for all chemiluminescent detection (Pierce, Rockford, IL).
Data analysis. Pooled data are presented as mean 6 SEM. Dose–response curves
were fitted by an equation of the form E 5 Emax{1/[1 1 (EC50/C)n]}, where E is the
effect at concentration C, Emax is maximal effect, EC50 is the concentration for half-
maximal effect and n is the Hill coefficient33. Statistical comparisons were made using
Figure 8 | Depletion of PIP2 inhibits Mg21 currents and eliminates Mg21
influx through TRPM6. (A) Mg21 currents recorded using isotonic
extracellular Mg21 in cells transfected with either TRPM6 alone (blue) or
TRPM61Ci-VSP (red).Mg21 current (blue) was significantly increased by
2-APB (green), and completely inhibited after PIP2 depletion induced
by activation of Ci-VSP. (B) Normalized Mg21 current amplitude (n59).
(C) Mg21 influx through TRPM6 under control conditions and after PIP2
hydrolysis by 200 mM CCh. Changes of Mg21 influx were measured in
isotonic Mg21 extracellular solution. Note the normalized fluorescence
intensity (F/F0) induced by isotonic Mg
21 was largely diminished by CCH.
(D) Average changes of F/F0 (n533,36 in each group).
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ANALYSIS of variance (ANOVA) and two-tailed t-test with Bonferroni correction.
P , 0.05 indicated statistical significance.
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